5,8,11-eicosatriynoic acid has been researched along with quinacrine in 1 studies
*Quinacrine: An acridine derivative formerly widely used as an antimalarial but superseded by chloroquine in recent years. It has also been used as an anthelmintic and in the treatment of giardiasis and malignant effusions. It is used in cell biological experiments as an inhibitor of phospholipase A2. [MeSH]
*Quinacrine: An acridine derivative formerly widely used as an antimalarial but superseded by chloroquine in recent years. It has also been used as an anthelmintic and in the treatment of giardiasis and malignant effusions. It is used in cell biological experiments as an inhibitor of phospholipase A2. [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Frey, JR; Henriksen, O | 1 |
1 other study(ies) available for 5,8,11-eicosatriynoic acid and quinacrine
| Article | Year |
|---|---|
Control of the expression of interleukin-2 activity.
Topics: Animals; Fatty Acids; Fatty Acids, Unsaturated; Interleukin-2; Lymphocyte Activation; Mice; Mice, Inbred BALB C; Phospholipases A; Puromycin; Quinacrine; Rats; Rats, Inbred Lew; Tetracaine | 1982 |